» Articles » PMID: 32389615

The Potential Impact of COVID-19 on Psychosis: A Rapid Review of Contemporary Epidemic and Pandemic Research

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2020 May 12
PMID 32389615
Citations 168
Authors
Affiliations
Soon will be listed here.
Abstract

The COVID-19 outbreak may profoundly impact population mental health because of exposure to substantial psychosocial stress. An increase in incident cases of psychosis may be predicted. Clinical advice on the management of psychosis during the outbreak needs to be based on the best available evidence. We undertook a rapid review of the impact of epidemic and pandemics on psychosis. Fourteen papers met inclusion criteria. Included studies reported incident cases of psychosis in people infected with a virus of a range of 0.9% to 4%. Psychosis diagnosis was associated with viral exposure, treatments used to manage the infection, and psychosocial stress. Clinical management of these patients, where adherence with infection control procedures is paramount, was challenging. Increased vigilance for psychosis symptoms in patients with COVID-19 is warranted. How to support adherence to physical distancing requirements and engagement with services in patients with existing psychosis requires careful consideration. Registration details: https://osf.io/29pm4.

Citing Articles

Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19.

Bravve L, Kaydan M, Kostyuk G Medicina (Kaunas). 2025; 61(2).

PMID: 40005415 PMC: 11857278. DOI: 10.3390/medicina61020298.


Early intervention in psychosis programs in Africa, Asia and Latin America; challenges and recommendations.

van der Ven E, Yang X, Mascayano F, Weinreich K, Chen E, Tang C Glob Ment Health (Camb). 2025; 12():e3.

PMID: 39781337 PMC: 11704378. DOI: 10.1017/gmh.2024.78.


Neurobiology of COVID-19-Associated Psychosis/Schizophrenia: Implication of Epidermal Growth Factor Receptor Signaling.

Nawa H, Murakami M Neuropsychopharmacol Rep. 2025; 45(1):e12520.

PMID: 39754403 PMC: 11702486. DOI: 10.1002/npr2.12520.


The Mediating Role of Social Support on Unmet Healthcare Needs in Vietnamese Older People During the COVID-19.

Giang L, Bui T, Le D, Truong V, To A Inquiry. 2024; 61:469580241304247.

PMID: 39610056 PMC: 11605764. DOI: 10.1177/00469580241304247.


Assessing Post-traumatic Stress Disorder and Social Determinants Among COVID-19 Case-Contact Dyads in Household Settings.

Ajay A, Tharakan A, Sreedevi A, C V L Cureus. 2024; 16(9):e68425.

PMID: 39360043 PMC: 11445670. DOI: 10.7759/cureus.68425.


References
1.
Chan S, Chiu F, Lam C, Leung P, Conwell Y . Elderly suicide and the 2003 SARS epidemic in Hong Kong. Int J Geriatr Psychiatry. 2006; 21(2):113-8. DOI: 10.1002/gps.1432. View

2.
Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y . Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics. 2002; 42(6):461-6. DOI: 10.1176/appi.psy.42.6.461. View

3.
Iancu I, Strous R, Poreh A, Kotler M, Chelben Y . Psychiatric inpatients' reactions to the SARS epidemic: an Israeli survey. Isr J Psychiatry Relat Sci. 2006; 42(4):258-62. View

4.
Sheng B, Cheng S, Lau K, Li H, Chan E . The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases. Eur Psychiatry. 2005; 20(3):236-42. PMC: 7135192. DOI: 10.1016/j.eurpsy.2004.06.023. View

5.
Russell B, Moss C, Rigg A, Van Hemelrijck M . COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?. Ecancermedicalscience. 2020; 14:1023. PMC: 7105332. DOI: 10.3332/ecancer.2020.1023. View